Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001567619-21-017949 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-05 | 2021-10-01 | TXG | McAnear Justin J. | CFO | S - Sale+OE | $143.52 | -10.0K | 48.5K | -17% | -$1.44M |
| D | 2021-10-05 | 2021-10-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $5.04 | +10.0K | 49.1K | +26% | +$50.4K |
| D | 2021-10-05 | 2021-10-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $0.00 | -10.0K | 380.2K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-10-01 | S | D | 2,500 | $142.80 | 45,966 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $142.25 to $143.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-10-01 | S | D | 1,200 | $144.57 | 39,100 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $144.325 to $145.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-10-01 | S | D | 5,666 | $143.79 | 40,300 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $143.30 to $144.275. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-10-01 | M | A | 10,000 | $5.04 | 49,100 | D | — | — | |
| 5 | Common | Class A Common Stock | 2021-10-01 | S | D | 634 | $141.96 | 48,466 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $141.25 to $142.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Derivative | Stock Option (right to buy) | 2021-10-01 | M | D | 10,000 | $0.00 | 380,159 | D | $5.04 · — to 2028-11-02 | 10,000 Class A Common Stock | (F6) This option, originally for 600,000 shares, of which 219,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |